|Articles|August 1, 2001

Pharmaceutical Technology

  • Pharmaceutical Technology-08-01-2001
  • Volume 2001 Supplement
  • Issue 2

The Squeeze in Contract Manufacturing

The demand for CGMP production of biopharmaceuticals is at an all-time high.


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.